|
|
|
|
|
About Us
|
|
Sales Rep Nightmares: Emerging Issues in Marketing Compliance
FDLI Update
by John Patrick Oroho and Christine N. Bradshaw
Over the past several years, prescription drug companies have been required to report to various state agencies the promotional expenses incurred in their interactions with healthcare practitioners (HCPs). Medical device companies are increasingly subject to these state disclosure laws as well.
Read entire article – click here
|
|
| |
|